27-05-2025
Tomei Consolidated Berhad First Quarter 2025 Earnings: EPS: RM0.20 (vs RM0.15 in 1Q 2024)
Revenue: RM348.0m (up 7.8% from 1Q 2024).
Net income: RM27.8m (up 33% from 1Q 2024).
Profit margin: 8.0% (up from 6.5% in 1Q 2024). The increase in margin was driven by higher revenue.
EPS: RM0.20 (up from RM0.15 in 1Q 2024).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Tomei Consolidated Berhad shares are up 1.2% from a week ago.
We should say that we've discovered 3 warning signs for Tomei Consolidated Berhad (1 is a bit unpleasant!) that you should be aware of before investing here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
